Identification of Neuritin 1 as a local metabolic regulator of brown adipose tissue.
Saved in:
| Title: | Identification of Neuritin 1 as a local metabolic regulator of brown adipose tissue. |
|---|---|
| Authors: | Sánchez-Feutrie M; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain. manuela.sanchez@irbbarcelona.org.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain. manuela.sanchez@irbbarcelona.org.; Departament de Biologia Cel.lular, Fisiologia i Immunologia, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain. manuela.sanchez@irbbarcelona.org.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain. manuela.sanchez@irbbarcelona.org., Romero M; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.; Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona (UB), 08028, Barcelona, Spain., Veiga SR; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain., Borràs-Ferré N; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.; Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona (UB), 08028, Barcelona, Spain., Berrow N; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain., Ràfols M; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain., Giménez N; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain., Rodgers-Furones A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Medical BioSciences department, RadboudUMC, Geert Grooteplein 28, 6525, GA, Nijmegen, The Netherlands., Sabaté-Pérez A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Rodríguez Pérez Á; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain., Cataldo LR; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Unit of Molecular Metabolism, Lund University Diabetes Centre, SE-20213, Malmö, Sweden.; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, 2200, Denmark., Burghardt H; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain., Sebastián D; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, University of Barcelona, 08028, Barcelona, Spain., Plana N; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain., Hernández V; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain., Alcaide LI; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain., Reina Ó; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain., Monte MJ; Experimental Hepatology and Drug Targeting (HEVEPHARM), Universidad de Salamanca; Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), ISCIII, Madrid, Spain., Marin JJG; Experimental Hepatology and Drug Targeting (HEVEPHARM), Universidad de Salamanca; Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), ISCIII, Madrid, Spain., Palacín M; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain.; CIBER de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Burcelin R; UMR 1297 INSERM, Team INCOMM Rangueil Hospital, Toulouse, 31400, France., Antonson P; Department of Medicine Huddinge, Karolinska Institutet, Neo, SE-141 83, Huddinge, Sweden., Gustafsson JA; Department of Medicine Huddinge, Karolinska Institutet, Neo, SE-141 83, Huddinge, Sweden.; Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, TX, 77204, USA., Zorzano A; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain. antonio.zorzano@irbbarcelona.org.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain. antonio.zorzano@irbbarcelona.org.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain. antonio.zorzano@irbbarcelona.org. |
| Source: | Nature communications [Nat Commun] 2025 Sep 04; Vol. 16 (1), pp. 7033. Date of Electronic Publication: 2025 Sep 04. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40908286 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Identification of Neuritin 1 as a local metabolic regulator of brown adipose tissue. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sánchez-Feutrie+M%22">Sánchez-Feutrie M</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain. manuela.sanchez@irbbarcelona.org.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain. manuela.sanchez@irbbarcelona.org.; Departament de Biologia Cel.lular, Fisiologia i Immunologia, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain. manuela.sanchez@irbbarcelona.org.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain. manuela.sanchez@irbbarcelona.org.<br /><searchLink fieldCode="AU" term="%22Romero+M%22">Romero M</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.; Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona (UB), 08028, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Veiga+SR%22">Veiga SR</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Borràs-Ferré+N%22">Borràs-Ferré N</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.; Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona (UB), 08028, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Berrow+N%22">Berrow N</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Ràfols+M%22">Ràfols M</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Giménez+N%22">Giménez N</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodgers-Furones+A%22">Rodgers-Furones A</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Medical BioSciences department, RadboudUMC, Geert Grooteplein 28, 6525, GA, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Sabaté-Pérez+A%22">Sabaté-Pérez A</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Rodríguez+Pérez+Á%22">Rodríguez Pérez Á</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Cataldo+LR%22">Cataldo LR</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Unit of Molecular Metabolism, Lund University Diabetes Centre, SE-20213, Malmö, Sweden.; Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, 2200, Denmark.<br /><searchLink fieldCode="AU" term="%22Burghardt+H%22">Burghardt H</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Sebastián+D%22">Sebastián D</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.; Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, University of Barcelona, 08028, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Plana+N%22">Plana N</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Hernández+V%22">Hernández V</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Alcaide+LI%22">Alcaide LI</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Reina+Ó%22">Reina Ó</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Monte+MJ%22">Monte MJ</searchLink>; Experimental Hepatology and Drug Targeting (HEVEPHARM), Universidad de Salamanca; Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), ISCIII, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Marin+JJG%22">Marin JJG</searchLink>; Experimental Hepatology and Drug Targeting (HEVEPHARM), Universidad de Salamanca; Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), ISCIII, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Palacín+M%22">Palacín M</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain.; CIBER de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Burcelin+R%22">Burcelin R</searchLink>; UMR 1297 INSERM, Team INCOMM Rangueil Hospital, Toulouse, 31400, France.<br /><searchLink fieldCode="AU" term="%22Antonson+P%22">Antonson P</searchLink>; Department of Medicine Huddinge, Karolinska Institutet, Neo, SE-141 83, Huddinge, Sweden.<br /><searchLink fieldCode="AU" term="%22Gustafsson+JA%22">Gustafsson JA</searchLink>; Department of Medicine Huddinge, Karolinska Institutet, Neo, SE-141 83, Huddinge, Sweden.; Center for Nuclear Receptors and Cell Signaling, Department of Biology and Biochemistry, University of Houston, Houston, TX, 77204, USA.<br /><searchLink fieldCode="AU" term="%22Zorzano+A%22">Zorzano A</searchLink>; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Baldiri Reixac 10, 08028, Barcelona, Spain. antonio.zorzano@irbbarcelona.org.; Departament de Bioquímica i Biomedicina Molecular, Facultat de Biologia, Universitat de Barcelona, Av. Diagonal 645, 08028, Barcelona, Spain. antonio.zorzano@irbbarcelona.org.; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain. antonio.zorzano@irbbarcelona.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2025 Sep 04; Vol. 16 (1), pp. 7033. <i>Date of Electronic Publication: </i>2025 Sep 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40908286 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-025-62255-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 7033 Titles: – TitleFull: Identification of Neuritin 1 as a local metabolic regulator of brown adipose tissue. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sánchez-Feutrie M – PersonEntity: Name: NameFull: Romero M – PersonEntity: Name: NameFull: Veiga SR – PersonEntity: Name: NameFull: Borràs-Ferré N – PersonEntity: Name: NameFull: Berrow N – PersonEntity: Name: NameFull: Ràfols M – PersonEntity: Name: NameFull: Giménez N – PersonEntity: Name: NameFull: Rodgers-Furones A – PersonEntity: Name: NameFull: Sabaté-Pérez A – PersonEntity: Name: NameFull: Rodríguez Pérez Á – PersonEntity: Name: NameFull: Cataldo LR – PersonEntity: Name: NameFull: Burghardt H – PersonEntity: Name: NameFull: Sebastián D – PersonEntity: Name: NameFull: Plana N – PersonEntity: Name: NameFull: Hernández V – PersonEntity: Name: NameFull: Alcaide LI – PersonEntity: Name: NameFull: Reina Ó – PersonEntity: Name: NameFull: Monte MJ – PersonEntity: Name: NameFull: Marin JJG – PersonEntity: Name: NameFull: Palacín M – PersonEntity: Name: NameFull: Burcelin R – PersonEntity: Name: NameFull: Antonson P – PersonEntity: Name: NameFull: Gustafsson JA – PersonEntity: Name: NameFull: Zorzano A IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 09 Text: 2025 Sep 04 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 16 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |